Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
79.30
+10.76 (15.70%)
At close: Mar 31, 2026, 4:00 PM EDT
79.22
-0.08 (-0.10%)
After-hours: Mar 31, 2026, 4:10 PM EDT
Sol-Gel Technologies Market Cap
Sol-Gel Technologies has a market cap or net worth of $259.23 million as of March 31, 2026. Its market cap has increased by 1,572.46% in one year.
Market Cap
259.23M
Enterprise Value
235.96M
1-Year Change
1,572.46%
Ranking
Category
Stock Price
$79.30
Market Cap Chart
Since February 1, 2018, Sol-Gel Technologies's market cap has increased from $228.30M to $259.23M, an increase of 13.55%. That is a compound annual growth rate of 1.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 191.00M | 62.69% |
| Dec 31, 2025 | 117.40M | 353.28% |
| Dec 31, 2024 | 25.90M | -15.91% |
| Dec 29, 2023 | 30.80M | -70.81% |
| Dec 30, 2022 | 105.50M | -38.34% |
| Dec 31, 2021 | 171.10M | -24.02% |
| Dec 31, 2020 | 225.20M | -35.58% |
| Dec 31, 2019 | 349.60M | 206.94% |
| Dec 31, 2018 | 113.90M | -50.11% |
| Feb 1, 2018 | 228.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAB Biotherapeutics | 270.56M |
| ALX Oncology Holdings | 268.48M |
| AC Immune | 267.84M |
| Minerva Neurosciences | 267.44M |
| Protara Therapeutics | 267.18M |
| Foghorn Therapeutics | 264.15M |
| LENZ Therapeutics | 263.38M |
| Anavex Life Sciences | 261.33M |